Unknown EARLY_PHASE1 INTERVENTIONAL 3-arm NCT06149091

Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid, Adrenalin and Hemagglutinase

Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid，Adrenalin and Hemagglutinase: a Double-blind Randomized Controlled Trial

Sponsor: China-Japan Friendship Hospital

Conditions Iatrogenic Endobronchial Bleeding

Interventions Adrenalin Hemagglutinase Tranexamic Acid；

Updated 5 times since 2023 Last updated: Nov 20, 2023 Started: Dec 1, 2023 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Iatrogenic Endobronchial Bleeding and is currently ongoing. China-Japan Friendship Hospital leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Unknown EARLY_PHASE1

Status: Recruiting → Unknown
Sep 2025 — Jan 2026 [monthly]

Recruiting EARLY_PHASE1
Sep 2024 — Sep 2025 [monthly]

Recruiting EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting EARLY_PHASE1
Dec 2023 — Jul 2024 [monthly]

Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

China-Japan Friendship Hospital
The First Affiliated Hospital of Nanchang University
The Second Affiliated Hospital of Harbin Medical University

Data source: China-Japan Friendship Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China